CHRS RSI Chart
Last 7 days
1.9%
Last 30 days
0.5%
Last 90 days
-21.7%
Trailing 12 Months
-57.0%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 301.9M | 0 | 0 | 0 |
2023 | 183.4M | 181.9M | 211.1M | 257.2M |
2022 | 303.6M | 276.1M | 239.1M | 211.0M |
2021 | 442.7M | 394.6M | 363.6M | 326.6M |
2020 | 435.1M | 487.4M | 489.3M | 475.8M |
2019 | 284.9M | 308.6M | 332.3M | 356.1M |
2017 | 0 | 213.8M | 237.5M | 261.2M |
2016 | 36.6M | 43.8M | 199.5M | 190.1M |
2015 | 33.3M | 35.2M | 26.3M | 30.0M |
2014 | 5.8M | 10.3M | 25.8M | 31.1M |
2013 | 2.1M | 2.3M | 2.5M | 2.8M |
2012 | 0 | 0 | 0 | 1.9M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Feb 09, 2024 | wahlstrom mats | gifted | - | - | -99,988 | - |
Feb 09, 2024 | wahlstrom mats | gifted | - | - | 99,988 | - |
Feb 01, 2024 | wahlstrom mats | acquired | 100,000 | 1.667 | 59,988 | - |
Jan 20, 2024 | lanfear dennis m | sold (taxes) | -27,371 | 2.44 | -11,218 | president & ceo |
Jan 20, 2024 | mcmichael bryan j | sold (taxes) | -4,165 | 2.44 | -1,707 | see remarks |
Jan 20, 2024 | reider paul | sold (taxes) | -11,843 | 2.44 | -4,854 | chief commercial officer |
Jan 07, 2024 | mcmichael bryan j | sold (taxes) | -4,899 | 2.87 | -1,707 | see remarks |
Jan 04, 2024 | reider paul | sold (taxes) | -6,643 | 2.92 | -2,275 | chief commercial officer |
Jan 04, 2024 | lanfear dennis m | sold (taxes) | -34,400 | 2.92 | -11,781 | president & ceo |
Dec 31, 2023 | stilwell mcdavid | sold (taxes) | -61,405 | 3.33 | -18,440 | chief financial officer |
Which funds bought or sold CHRS recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 15, 2024 | TWO SIGMA INVESTMENTS, LP | added | 0.8 | -1,335,460 | 3,494,210 | 0.01% |
May 15, 2024 | DISCIPLINED GROWTH INVESTORS INC /MN | added | 7.65 | -883,512 | 3,001,690 | 0.06% |
May 15, 2024 | PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | sold off | -100 | -13,320 | - | -% |
May 15, 2024 | D. E. Shaw & Co., Inc. | sold off | -100 | -424,941 | - | -% |
May 15, 2024 | CAPTRUST FINANCIAL ADVISORS | new | - | 25,112 | 25,112 | -% |
May 15, 2024 | Royal Bank of Canada | reduced | -85.47 | -96,000 | 11,000 | -% |
May 15, 2024 | Point72 Asia (Singapore) Pte. Ltd. | reduced | -82.36 | -56,198 | 8,144 | -% |
May 15, 2024 | QUADRANT CAPITAL GROUP LLC | sold off | -100 | -1,522 | - | -% |
May 15, 2024 | Kohlberg Kravis Roberts & Co. L.P. | unchanged | - | -2,853,910 | 7,256,220 | 0.19% |
May 15, 2024 | Tower Research Capital LLC (TRC) | sold off | -100 | -43,300 | - | -% |
Unveiling Coherus Biosciences Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Coherus Biosciences Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.52 | 7.43 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 19.1B | 2.0B | -57.61 | 9.55 | ||||
BMRN | 14.6B | 2.5B | 71.11 | 5.91 | ||||
INCY | 12.8B | 3.8B | 17.13 | 3.39 | ||||
MID-CAP | ||||||||
BBIO | 5.8B | 107.9M | -10.63 | 48.09 | ||||
APLS | 5.1B | 524.1M | -12.22 | 9.73 | ||||
AXSM | 3.7B | 251.0M | -12.4 | 14.64 | ||||
ARWR | 3.1B | 240.7M | -6.6 | 12.77 | ||||
ACAD | 2.5B | 813.8M | -1.4K | 3.01 | ||||
SMALL-CAP | ||||||||
NVAX | 2.0B | 996.6M | -5.07 | 2.03 | ||||
CPRX | 1.9B | 411.3M | 29.69 | 4.7 | ||||
CRBP | 489.5M | 881.7K | -14.5 | 481.06 | ||||
INO | 330.9M | 4.9M | -2.65 | 67.99 | ||||
IBIO | 15.7M | 2.1M | -0.68 | 7.61 |
Coherus Biosciences Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | -15.8% | 77,063,000 | 91,524,000 | 74,568,000 | 58,716,000 | 32,436,000 | 45,352,000 | 45,424,000 | 60,151,000 | 60,115,000 | 73,371,000 | 82,503,000 | 87,643,000 | 83,034,000 | 110,419,000 | 113,551,000 | 135,674,000 | 116,180,000 | 123,871,500 | 111,684,000 | 83,400,000 | 37,100,000 |
Costs and Expenses | -25.5% | 119,588,000 | 160,429,000 | 106,574,000 | 93,259,000 | 100,181,000 | 96,845,000 | 125,873,000 | 104,164,000 | 141,040,000 | 112,918,000 | 115,290,000 | 111,807,000 | 250,394,000 | 93,994,000 | 79,835,000 | 70,364,000 | 75,312,000 | - | - | - | - |
Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 79,835,000 | 70,364,000 | 75,312,000 | 78,823,000 | 59,843,000 | 55,940,000 | 53,697,000 |
S&GA Expenses | 14.2% | 56,532,000 | 49,494,000 | 48,224,000 | 45,144,000 | 49,153,000 | 53,621,000 | 44,831,000 | 51,276,000 | 48,753,000 | 50,052,000 | 39,925,000 | 40,345,000 | 39,391,000 | 37,693,000 | 31,984,000 | 34,052,000 | 35,350,000 | 36,070,000 | 31,828,000 | 36,456,000 | 32,683,000 |
R&D Expenses | 8.0% | 28,470,000 | 26,368,000 | 25,647,000 | 23,267,000 | 34,154,000 | 29,022,000 | 45,808,000 | 41,611,000 | 82,917,000 | 50,762,000 | 54,085,000 | 54,766,000 | 203,492,000 | 44,628,000 | 38,851,000 | 26,173,000 | 33,107,000 | 34,948,000 | 21,568,000 | 18,883,000 | 18,789,000 |
EBITDA Margin | 93.7% | -0.05 | -0.75 | -0.83 | -1.23 | -1.28 | -1.21 | -1.03 | -0.72 | -0.59 | -0.80 | -0.56 | -0.35 | - | - | - | - | - | - | - | - | - |
Interest Expenses | 4.7% | 11,116,000 | 10,619,000 | 10,268,000 | 9,943,000 | 9,712,000 | 9,385,000 | 7,540,000 | 6,580,000 | 8,969,000 | 5,793,000 | 5,771,000 | 5,747,000 | 5,648,000 | 5,671,000 | 5,656,000 | 5,408,000 | 4,431,000 | 4,483,000 | 4,469,000 | 4,433,000 | 4,216,000 |
Income Taxes | - | - | - | -380,000 | - | - | - | - | - | - | - | - | - | - | 1,049,500 | 200,000 | 1,294,000 | 933,000 | 2,066,500 | 800,000 | 51,000 | - |
Earnings Before Taxes | 229.2% | 102,875,000 | -79,653,000 | -40,021,000 | -42,869,000 | -75,729,000 | -58,870,000 | -86,650,000 | -50,150,000 | -96,084,000 | -45,725,000 | -38,528,000 | -29,900,000 | -172,947,000 | 10,760,500 | 28,116,000 | 60,325,000 | 36,505,000 | 41,271,000 | 47,890,000 | 23,618,000 | -20,004,000 |
EBT Margin | 78.7% | -0.20 | -0.93 | -1.03 | -1.45 | -1.48 | -1.38 | -1.17 | -0.83 | -0.69 | -0.88 | -0.63 | -0.42 | - | - | - | - | - | - | - | - | - |
Net Income | 229.2% | 102,875,000 | -79,653,000 | -39,641,000 | -42,869,000 | -75,729,000 | -58,870,000 | -86,650,000 | -50,150,000 | -96,084,000 | -45,725,000 | -38,528,000 | -29,900,000 | -172,947,000 | 9,708,000 | 27,933,000 | 59,031,000 | 35,572,000 | 39,227,000 | 47,043,000 | 23,567,000 | -20,004,000 |
Net Income Margin | 78.8% | -0.20 | -0.92 | -1.03 | -1.45 | -1.48 | -1.38 | -1.17 | -0.83 | -0.69 | -0.88 | -0.64 | -0.42 | - | - | - | - | - | - | - | - | - |
Free Cashflow | -260.8% | -46,800,000 | -12,971,000 | -54,300,000 | -39,015,000 | -68,884,000 | -100,040,000 | -37,546,000 | -50,917,000 | -54,660,000 | -52,790,000 | 13,450,000 | -603,000 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | 21.3% | 764 | 630 | 584 | 470 | 402 | 481 | 551 | 546 | 593 | 679 | 742 | 740 | 693 | 842 | 804 | 757 | 467 | 409 | 327 | 240 | 186 |
Current Assets | 31.9% | 627 | 476 | 444 | 385 | 316 | 381 | 448 | 447 | 512 | 602 | 673 | 660 | 617 | 767 | 727 | 676 | 395 | 343 | 276 | 206 | 159 |
Cash Equivalents | 152.9% | 260 | 103 | 80.00 | 73.00 | 16.00 | 64.00 | 287 | 275 | 326 | 417 | 361 | 330 | 259 | 541 | 292 | 225 | 193 | 178 | 165 | 106 | 82.00 |
Inventory | -1.0% | 62.00 | 63.00 | 67.00 | 64.00 | 49.00 | 39.00 | 28.00 | 32.00 | 37.00 | 38.00 | 38.00 | 40.00 | 52.00 | 44.00 | 35.00 | 27.00 | 16.00 | 10.00 | 8.00 | 4.00 | 2.00 |
Net PPE | -18.2% | 4.00 | 5.00 | 6.00 | 7.00 | 8.00 | 9.00 | 10.00 | 10.00 | 8.00 | 8.00 | - | - | - | 10.00 | - | 10.00 | 7.00 | 6.00 | 6.00 | 6.00 | 6.00 |
Goodwill | -100.0% | - | 1.00 | - | - | - | 1.00 | - | - | - | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Liabilities | 2.7% | 845 | 823 | 717 | 644 | 599 | 618 | 648 | 569 | 581 | 582 | 611 | 583 | 566 | 561 | 548 | 543 | 309 | 304 | 271 | 244 | 225 |
Current Liabilities | 62.3% | 538 | 332 | 240 | 169 | 123 | 139 | 171 | 141 | 154 | 165 | 320 | 287 | 258 | 146 | 133 | 130 | 119 | 115 | 83.00 | 61.00 | 41.00 |
Shareholder's Equity | 57.7% | -81.84 | -193 | - | - | -196 | -137 | - | - | 13.00 | 98.00 | 131 | 156 | 128 | 281 | 256 | 213 | 157 | 105 | 56.00 | 0.00 | - |
Retained Earnings | 6.5% | -1,476 | -1,579 | -1,499 | -1,460 | -1,417 | -1,341 | -1,282 | -1,196 | -1,145 | -1,049 | -1,004 | -965 | -935 | -762 | -772 | -800 | -859 | -895 | -934 | -981 | -1,004 |
Additional Paid-In Capital | 0.6% | 1,395 | 1,386 | 1,367 | 1,286 | 1,221 | 1,204 | 1,186 | 1,174 | 1,159 | 1,148 | 1,135 | 1,122 | 1,064 | 1,044 | 1,028 | 1,014 | 1,017 | 1,001 | 991 | 978 | 967 |
Shares Outstanding | 1.1% | 113 | 112 | 109 | 94.00 | 80.00 | 79.00 | 78.00 | 78.00 | 77.00 | 75.00 | 75.00 | 76.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 324 | - | - | - | 444 | - | - | - | 837 | - | - | - | 900 | - | - | - | 1,400 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -261.5% | -46,766 | -12,937 | -54,300 | -38,915 | -68,732 | -99,953 | -37,089 | -50,037 | -54,045 | -52,322 | 13,711 | -188 | 1,367 | 33,124 | 47,353 | 60,191 | 13,477 | 17,710 | 54,951 | 12,677 | -56,983 |
Share Based Compensation | -32.2% | 7,319 | 10,798 | 9,953 | 10,077 | 12,282 | 11,726 | 12,282 | 13,850 | 12,879 | 10,946 | 11,939 | 11,595 | 16,884 | 9,873 | 9,307 | 9,425 | 9,555 | 7,272 | 8,833 | 7,992 | 9,494 |
Cashflow From Investing | 476.0% | 202,763 | 35,203 | 50,546 | 41,365 | 17,526 | -129,898 | -457 | -880 | -35,615 | 107,490 | 15,990 | 23,585 | -285,475 | 210,056 | 16,407 | -239,248 | -1,616 | -6,062 | -289 | 8,818 | -15,199 |
Cashflow From Financing | 142.3% | 887 | 366 | 11,105 | 54,325 | 3,804 | 6,593 | 48,867 | 721 | -1,855 | 1,487 | 1,101 | 46,852 | 2,439 | 5,513 | 4,088 | 210,422 | 3,923 | 1,200 | 3,683 | 3,010 | 81,477 |
Condensed Consolidated Statements of Operations - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Revenue: | ||
Net revenue | $ 77,063 | $ 32,436 |
Costs and expenses: | ||
Cost of goods sold | 34,586 | 16,874 |
Research and development | 28,470 | 34,154 |
Selling, general and administrative | 56,532 | 49,153 |
Total costs and expenses | 119,588 | 100,181 |
Loss from operations | (42,525) | (67,745) |
Interest expense | (11,116) | (9,712) |
Gain on Sale Transaction, net (Note 6) | 153,647 | |
Other income (expense), net | 2,869 | 1,728 |
Income (loss) before income taxes | 102,875 | (75,729) |
Net income (loss) | $ 102,875 | $ (75,729) |
Net Income (Loss) Per Share | ||
Basic (In dollar per share) | $ 0.91 | $ (0.96) |
Diluted (In dollar per share) | $ 0.83 | $ (0.96) |
Weighted-average number of shares used in computing net income (loss) per share: | ||
Basic (In shares) | 112,749,306 | 79,268,853 |
Diluted (In shares) | 125,529,971 | 79,268,853 |
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 259,775 | $ 102,891 |
Investments in marketable securities | 14,857 | |
Trade receivables, net | 251,951 | 260,522 |
TSA receivables, net (Note 6) | 32,194 | |
Inventory | 61,978 | 62,605 |
Prepaid manufacturing | 7,498 | 23,657 |
Other prepaids and current assets | 14,081 | 11,099 |
Total current assets | 627,477 | 475,631 |
Property and equipment, net | 4,188 | 5,119 |
Inventory, non-current | 65,645 | 67,495 |
Intangible assets, net | 57,104 | 71,673 |
Other assets, non-current | 9,131 | 9,686 |
Total assets | 763,545 | 629,604 |
Current liabilities: | ||
Accounts payable | 38,289 | 35,219 |
Accrued rebates, fees and reserves | 155,775 | 169,645 |
TSA payables and other accrued liabilities (Note 6) | 30,770 | |
Accrued compensation | 22,762 | 21,521 |
Accrued and other current liabilities | 115,707 | 105,386 |
Term loans, current | 175,000 | |
Total current liabilities | 538,303 | 331,771 |
Term loans, non-current | 72,452 | 246,481 |
Convertible notes | 227,220 | 226,888 |
Lease liabilities, non-current | 4,680 | 5,328 |
Other liabilities, non-current | 2,734 | 12,561 |
Total liabilities | 845,389 | 823,029 |
Commitments and contingencies (Note 9) | ||
Stockholders' deficit: | ||
Common stock ($0.0001 par value; shares authorized: 300,000,000; shares issued and outstanding: 113,496,854 and 112,215,260 at March 31, 2024 and December 31, 2023, respectively) | 11 | 11 |
Additional paid-in capital | 1,395,042 | 1,386,312 |
Accumulated other comprehensive loss | (272) | (248) |
Accumulated deficit | (1,476,625) | (1,579,500) |
Total stockholders' deficit | (81,844) | (193,425) |
Total liabilities and stockholders' deficit | $ 763,545 | $ 629,604 |